# The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

> **NCT03180333** · PHASE1 · COMPLETED · sponsor: **Guangzhou Yipinhong Pharmaceutical CO.,LTD** · enrollment: 16 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** PNA
- **DRUG:** PNA placebo

## Key facts

- **NCT ID:** NCT03180333
- **Lead sponsor:** Guangzhou Yipinhong Pharmaceutical CO.,LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180333, "The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03180333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*